Menu
GeneBe

20-3889134-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6

The ENST00000316562.9(PANK2):c.34C>T(p.His12Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000723 in 1,562,132 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000040 ( 1 hom. )

Consequence

PANK2
ENST00000316562.9 missense

Scores

1
7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -0.301
Variant links:
Genes affected
PANK2 (HGNC:15894): (pantothenate kinase 2) This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]
PANK2-AS1 (HGNC:40732): (PANK2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03422314).
BP6
Variant 20-3889134-C-T is Benign according to our data. Variant chr20-3889134-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 935319.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PANK2-AS1XR_001754478.3 linkuse as main transcriptn.40G>A non_coding_transcript_exon_variant 1/2
PANK2NM_153638.4 linkuse as main transcriptc.34C>T p.His12Tyr missense_variant 1/7
PANK2NM_001324192.1 linkuse as main transcriptc.34C>T p.His12Tyr missense_variant 1/2
PANK2NM_024960.6 linkuse as main transcriptc.-246+230C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PANK2ENST00000316562.9 linkuse as main transcriptc.34C>T p.His12Tyr missense_variant 1/71 A2Q9BZ23-1
PANK2-AS1ENST00000702266.1 linkuse as main transcriptn.40G>A non_coding_transcript_exon_variant 1/1
PANK2ENST00000495692.5 linkuse as main transcriptc.-538+118C>T intron_variant 3
PANK2ENST00000497424.5 linkuse as main transcriptc.-246+230C>T intron_variant 2 Q9BZ23-2

Frequencies

GnomAD3 genomes
AF:
0.000374
AC:
57
AN:
152214
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000703
AC:
12
AN:
170798
Hom.:
0
AF XY:
0.0000328
AC XY:
3
AN XY:
91350
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000146
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000404
AC:
57
AN:
1409800
Hom.:
1
Cov.:
31
AF XY:
0.0000302
AC XY:
21
AN XY:
696472
show subpopulations
Gnomad4 AFR exome
AF:
0.00146
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000461
Gnomad4 OTH exome
AF:
0.0000857
GnomAD4 genome
AF:
0.000368
AC:
56
AN:
152332
Hom.:
0
Cov.:
33
AF XY:
0.000376
AC XY:
28
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.00130
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000296
Hom.:
0
Bravo
AF:
0.000423
ESP6500AA
AF:
0.000919
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000504
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 08, 2024Variant summary: PANK2 c.34C>T (p.His12Tyr) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7e-05 in 170798 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in PANK2 causing Pantothenate Kinase-Associated Neurodegeneration (7e-05 vs 0.0011), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.34C>T in individuals affected with Pantothenate Kinase-Associated Neurodegeneration and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 935319). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 02, 2023The c.34C>T (p.H12Y) alteration is located in exon 1 (coding exon 1) of the PANK2 gene. This alteration results from a C to T substitution at nucleotide position 34, causing the histidine (H) at amino acid position 12 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Pigmentary pallidal degeneration Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 19, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.11
Cadd
Benign
15
Dann
Uncertain
1.0
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.59
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.39
T
M_CAP
Uncertain
0.29
D
MetaRNN
Benign
0.034
T
MetaSVM
Uncertain
0.094
D
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
D;N
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.49
N
REVEL
Uncertain
0.32
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.051
T
Polyphen
0.0
B
Vest4
0.21
MVP
0.85
MPC
0.59
ClinPred
0.23
T
GERP RS
3.6
Varity_R
0.30
gMVP
0.040

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374286033; hg19: chr20-3869781; API